{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T09:43:34Z","timestamp":1784367814080,"version":"3.55.0"},"reference-count":88,"publisher":"FapUNIFESP (SciELO)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq Bras Endocrinol Metab"],"published-print":{"date-parts":[[2005,12]]},"abstract":"<jats:p>A introdu\u00e7\u00e3o da highly active antiretroviral therapy (HAART) - terapia anti-retroviral fortemente ativa - vem reduzindo a morbidade e a mortalidade em pacientes infectados com o v\u00edrus da imunodefici\u00eancia humana (HIV). Entretanto, tratamentos prolongados, com combina\u00e7\u00f5es de drogas, s\u00e3o de dif\u00edcil manuten\u00e7\u00e3o devido \u00e0 m\u00e1 ader\u00eancia e aos efeitos t\u00f3xicos. O tratamento com agentes anti-retrovirais, especialmente os inibidores da protease, fez surgir uma s\u00edndrome caracterizada por redistribui\u00e7\u00e3o anormal da gordura corporal, altera\u00e7\u00f5es no metabolismo glic\u00eamico, resist\u00eancia insul\u00ednica e dislipidemia, chamada de s\u00edndrome lipodistr\u00f3fica do HIV (SLHIV). Atualmente n\u00e3o existe nenhum consenso para preven\u00e7\u00e3o ou tratamento da s\u00edndrome, cuja causa permanece desconhecida. Esta revis\u00e3o enfatiza os achados cl\u00ednicos e dados da literatura a respeito da SLHIV, pois um melhor entendimento desta s\u00edndrome por infectologistas, cardiologistas e endocrinologistas \u00e9 essencial para o manejo da doen\u00e7a.<\/jats:p>","DOI":"10.1590\/s0004-27302005000600004","type":"journal-article","created":{"date-parts":[[2006,4,19]],"date-time":"2006-04-19T09:59:50Z","timestamp":1145440790000},"page":"871-881","source":"Crossref","is-referenced-by-count":31,"title":["Altera\u00e7\u00f5es metab\u00f3licas da s\u00edndrome lipodistr\u00f3fica do HIV"],"prefix":"10.1590","volume":"49","author":[{"given":"Ang\u00e9lica M.M.","family":"Valente","sequence":"first","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 F.","family":"Reis","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy M.","family":"Machado","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina C.M.","family":"Succi","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio R.","family":"Chacra","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"issue":"23","key":"ref1","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1056\/NEJM200106073442306","article-title":"AIDS: The First 20 Years","volume":"344","author":"Sepkowitz KA","year":"2001","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref2","series-title":"AIDS Epidemic Update","year":"2002"},{"key":"ref3","series-title":"Epidemiologia da AIDS no Brasil"},{"issue":"11","key":"ref4","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1056\/NEJM199709113371102","article-title":"Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy","volume":"337","author":"Gulick RM","year":"1997","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"issue":"13","key":"ref5","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","volume":"338","author":"Palle Jr FJ","year":"1998","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"F63","DOI":"10.1097\/00002030-199907090-00001","article-title":"Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors","volume":"13","author":"Behrens G","year":"1999","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0140-6736(00)02854-3","article-title":"Adverse effects of antiretroviral therapy","volume":"356","author":"Carr A","year":"2000","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1086\/317541","article-title":"Metabolic abnormalities and cardiovascular disease risk factors in adults UIT human immunodeficiency virus infection and lipodystrophy","volume":"32","author":"Hadigan C","year":"2001","journal-title":"Clin Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1058-4838","issn-type":"print"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/01.SMJ.0000051731.69719.2E","article-title":"Lipodystrophy, insulin resistance, diabetes mellitus, dyslipidemia, and cardiovascular disease in human immunodeficiency virus infection","volume":"96","author":"Tanwani LK","year":"2003","journal-title":"Southern Med J"},{"issue":"2","key":"ref10","first-page":"229","article-title":"Adverse effects of antiretroviral therapy for HIV infection","volume":"170","author":"Montessori V","year":"2004","journal-title":"CMAJ","ISSN":"https:\/\/id.crossref.org\/issn\/0820-3946","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1086\/313995","article-title":"Coronary artery disease and human immunodeficiency virus infection","volume":"31","author":"Passalaris JD","year":"2000","journal-title":"Clin Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1058-4838","issn-type":"print"},{"key":"ref12","series-title":"FDA Public Health Advisory: Reports of diabetes and hyperglycemia in patients receiving protease inhibitors for the treatment of human immunodeficiency virus (HIV)","author":"Lumpkin M","year":"1997"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(97)11518-5","article-title":"Visceral abdominal: Fat accumulation associated UIT use of indinavir","volume":"351","author":"Miller KD","year":"1998","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1086\/514638","article-title":"Pseudo-Cushing's syndrome in human immunodeficiency virus-infected patients","volume":"27","author":"Miller KK","year":"1998","journal-title":"Clin Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1058-4838","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0140-6736(97)11443-X","article-title":"\"Buffalo Hump\" in men with HIV-1 infection","volume":"351","author":"Lo JC","year":"1998","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.1086\/313854","article-title":"HIV protease inhibitor: Related lipodystrophy syndrome","volume":"30","author":"Carr A","year":"2000","journal-title":"Clin Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1058-4838","issn-type":"print"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00002030-199903110-00004","article-title":"Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy","volume":"13","author":"Gervasoni C","year":"1999","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/368185","article-title":"Prediction of coronary heart disease risk in HIV-infected patients with fat redistribution","volume":"36","author":"Hadigan C","year":"2003","journal-title":"Clin Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1058-4838","issn-type":"print"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00041433-200402000-00011","article-title":"Pathophysiology of dyslipidemia and increased cardiovascular risk in HIV lipodystrophy: A model of \"systemic steatosis\"","volume":"15","author":"Balasubramanyan A","year":"2004","journal-title":"Curr Op Lipidol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0002-9343(89)90225-8","article-title":"Hypertriglyceridemia in the acquired immunodeficiency syndrome","volume":"86","author":"Grunfeld C","year":"1989","journal-title":"Am J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9343","issn-type":"print"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/01.CIR.100.7.700","article-title":"Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors","volume":"100","author":"P\u00e9riard D","year":"1999","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors","volume":"12","author":"Carr A","year":"1998","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1001\/archinte.160.13.2050","article-title":"Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: A 5-year cohort study","volume":"160","author":"Tsiodras S","year":"2000","journal-title":"Arch Inter Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/ije\/31.5.1016","article-title":"Incidence of morphological and lipid abnormalities: Gender and treatment differentials after initiation of first antiretroviral therapy","volume":"31","author":"Heath K","year":"2002","journal-title":"Intern J Epidemiol"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/00002030-199904160-00020","article-title":"Lipodystrophy in patients na\u00efve to HIV protease inhibitors","volume":"13","author":"Madge S","year":"1999","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00002030-200001070-00006","article-title":"Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects","volume":"14","author":"Purnell J","year":"2000","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/00002030-200305230-00010","article-title":"Cardiovascular disease risk factors in HIV patients - Association with antiretroviral therapy: Results from the DAD study","volume":"17","author":"Fr\u00fcs-Moller N","year":"2003","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00126334-200211010-00001","article-title":"Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: Recommendations of an international AIDS society - USA panel","volume":"31","author":"Schambelan M","year":"2002","journal-title":"J Acquir Immune Defic Syndr","ISSN":"https:\/\/id.crossref.org\/issn\/0894-9255","issn-type":"print"},{"key":"ref29","first-page":"248","article-title":"Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in adults: Adult treatment Panel III","volume":"285","year":"2001","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMra041811","article-title":"Cardiovascular risk and body-fat abnormalities in HIV-infected adults","volume":"352","author":"Grinspoon S","year":"2005","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/00002030-200203080-00008","article-title":"Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047","volume":"16","author":"Fichtenbaum CJ","year":"2002","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"issue":"2","key":"ref32","first-page":"161","article-title":"New onset diabetes mellitus associated with preotease inhibitor therapy in an HIV-positive patient: Case report and review","volume":"161","author":"Lee ECC","year":"1999","journal-title":"CMAF"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"F11","DOI":"10.1097\/00002030-200105040-00001","article-title":"Metabolic effects of indinavir in healthy HIV-seronegative men","volume":"15","author":"Noor MA","year":"2001","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1086\/317491","article-title":"Disorders of glucose metabolism in patients infected with human immunodeficiency virus","volume":"31","author":"Dube MP","year":"2000","journal-title":"Clin Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1058-4838","issn-type":"print"},{"issue":"4","key":"ref35","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1001\/jama.284.4.472","article-title":"Metformin in the treatment of HIV lipodystrophy syndrome: A randomized controlled trial","volume":"284","author":"Hadigan C","year":"2000","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1210\/jcem.86.2.7410","article-title":"Increased PAI-1 and tPA antigen levels are reduced UIT metformin therapy in HIV-infected patients UIT fat redistribution and insulin resistance","volume":"86","author":"Hadigan C","year":"2001","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"10","key":"ref37","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1210\/jc.2002-020709","article-title":"Sustained benefits of metformin therapy on markers of cardiovascular risk in human immunodeficiency virus-infected patients UIT fat redistribution and insulin resistance","volume":"87","author":"Hadigan C","year":"2002","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1056\/NEJMra025261","article-title":"Acquired and inherited lipodystrophies","volume":"350","author":"Garg A","year":"2004","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"786","DOI":"10.7326\/0003-4819-140-10-200405180-00008","article-title":"Metabolic effects of rosiglitazone in HIV lipodystrophy","volume":"140","author":"Hadigan C","year":"2004","journal-title":"Ann Intern Med","ISSN":"https:\/\/id.crossref.org\/issn\/0003-4819","issn-type":"print"},{"key":"ref40","first-page":"429","article-title":"Rosiglitazone does not improve antiretroviral-associated lipoatrophy","volume":"363","author":"Carr A","year":"2004","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/00002030-199909100-00009","article-title":"A Syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy","volume":"13","author":"Saint-Marc T","year":"1999","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"F25","DOI":"10.1097\/00002030-200002180-00001","article-title":"A syndrome of lipodystrophy, latic acidaemia and liver dysfunction associated with nucleoside analogue therapy: Contribution to protease inhibition -Related lipodystrophy syndrome","volume":"14","author":"Carr A","year":"2000","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1086\/317477","article-title":"Lipodystrophy, metabolic disorders, and human immunodeficiency virus infection: Aquitaine cohort, France, 1999","volume":"31","author":"Thi\u00e9baut R","year":"2000","journal-title":"Clin Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1058-4838","issn-type":"print"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1097\/00002030-200109280-00010","article-title":"HIV protease inhibitors substitution in patients with lipodystrophy: A randomized, controlled, open-label, multicentre study","volume":"15","author":"Carr A","year":"2001","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1086\/338402","article-title":"Reduction of abdominal obesity in lipodystrophy associated with human immunodeficiency virus infection by means of diet and exercise: Case report and proof of principle","volume":"34","author":"Roubenoff R","year":"2002","journal-title":"Clin Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1058-4838","issn-type":"print"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1097\/00002030-199907300-00015","article-title":"A pilot study of exercise training to reduce trunk fat in adults with HIV-associated fat redistribution","volume":"13","author":"Roubenoff R","year":"1999","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"873","DOI":"10.7326\/0003-4819-125-11-199612010-00002","article-title":"Recombinant human growth hormone in patients with HIV-associated wasting: A randomized, placebo-controlled trial","volume":"125","author":"Schambelan M","year":"1996","journal-title":"Ann Intern Med","ISSN":"https:\/\/id.crossref.org\/issn\/0003-4819","issn-type":"print"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1097\/00006534-199911000-00032","article-title":"Suction-assisted lipectomy for lipodystrophy syndromes attributed to HIV: Protease inhibitor use","volume":"104","author":"Wolfort FG","year":"1999","journal-title":"Plast Reconstr Surg","ISSN":"https:\/\/id.crossref.org\/issn\/0032-1052","issn-type":"print"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.2165\/00003495-200363160-00003","article-title":"Atazanavir","volume":"16","author":"Goldsmith DR","year":"2003","journal-title":"Drugs","ISSN":"https:\/\/id.crossref.org\/issn\/0012-6667","issn-type":"print"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00126334-200301010-00004","article-title":"Results of a phase 2 clinical trial at 48 weeks (AI 424-007) a dose-ranging safety, and efficacy comparative trial of atazanavir at three doses in combination with didanosine and stavudine in antiretroviral-na\u00efve subjects","volume":"1","author":"Sane I","year":"2003","journal-title":"J Acquir Immune Defic Syndr","ISSN":"https:\/\/id.crossref.org\/issn\/0894-9255","issn-type":"print"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1097\/00002030-200306130-00008","article-title":"Therapy with atazanavir plus saquinavir in the patients failing highly active antiretroviral therapy: A randomized comparative pilot trial","volume":"17","author":"Haas DW","year":"2003","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"issue":"6","key":"ref52","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1097\/00002030-200404090-00016","article-title":"Regression of lipodystrophy in HIV-infected patients under therapy with the new protease inhibitor atazanavir","volume":"18","author":"Haerter G","year":"2004","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"issue":"4","key":"ref53","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1053\/pcad.2003.5","article-title":"Epidemiology of HIV cardiac disease","volume":"45","author":"Cotter B","year":"2003","journal-title":"Progress Cardiov Dis"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1089\/aid.1998.14.1071","article-title":"Cardiac involvement in the acquired immunodeficiency syndrome: A multicentre clinical-pathological study","volume":"14","author":"Barbaro G","year":"1998","journal-title":"AIDS Res Hum Retrovir"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00042560-199806010-00006","article-title":"Cardiac manifestations of HIV \/ AIDS: A review of disease spectrum and clinical manegement","volume":"18","author":"Yunis NA","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol","ISSN":"https:\/\/id.crossref.org\/issn\/1077-9450","issn-type":"print"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1001\/archinte.160.5.602","article-title":"Cardiac manifestations of acquired immunodeficiency syndrome","volume":"160","author":"Rerkpattanapipat P","year":"2000","journal-title":"Arch Intern Med","ISSN":"https:\/\/id.crossref.org\/issn\/0003-9926","issn-type":"print"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0140-6736(05)79053-X","article-title":"Severe premature coronary artery disease with protease inhibitor (Letter)","volume":"351","author":"Henry K","year":"1998","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref58","first-page":"329","article-title":"Incidence of myocardial infarctions in HIV-infected patients between 1983 and 1998: The Frankfurt HIV-cohort study","volume":"5","author":"Rickerts V","year":"2000","journal-title":"Eur J Med Res","ISSN":"https:\/\/id.crossref.org\/issn\/0949-2321","issn-type":"print"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1056\/NEJM200106073442316","article-title":"HIV-associated coronary arteritis in a patient with fatal myocardial infarction","volume":"344","author":"Barbaro G","year":"2001","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"548","DOI":"10.7326\/0003-4819-131-7-199910050-00032","article-title":"Myocardial infarction in HIV-infected men receiving protease inhibitors","volume":"131","author":"Flynn TE","year":"1999","journal-title":"Ann Intern Med","ISSN":"https:\/\/id.crossref.org\/issn\/0003-4819","issn-type":"print"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1097\/00002030-200012010-00021","article-title":"Acceleration of confirmed coronary artery disease among HIV-infected patients on potent antiretroviral therapy","volume":"14","author":"Friedl AC","year":"2000","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref62","first-page":"261","article-title":"Arteriopaty in children with AIDS","volume":"7","author":"Joshi VV","year":"1987","journal-title":"Pediatr Pathol","ISSN":"https:\/\/id.crossref.org\/issn\/0277-0938","issn-type":"print"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0923-2516(06)80033-6","article-title":"Coronary artery lesions and human immunodeficiency virus infection","volume":"144","author":"Paton P","year":"1993","journal-title":"Res Virol","ISSN":"https:\/\/id.crossref.org\/issn\/0923-2516","issn-type":"print"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJM199201233260406","article-title":"The progression of coronary artery disease and the acute coronary syndromes","volume":"326","author":"Fuster V","year":"1992","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1056\/NEJM199201303260506","article-title":"The progression of coronary artery disease and the acute coronary syndromes","volume":"326","author":"Fuster V","year":"1992","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref66","first-page":"81","author":"Klein D","year":"2000"},{"issue":"8","key":"ref67","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1056\/NEJMoa022048","article-title":"Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection","volume":"348","author":"Bozzette SA","year":"2003","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction","volume":"349","year":"2003","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"860","DOI":"10.2337\/diab.46.5.860","article-title":"Production of plasminogen activator inhibitor 1 by human tissue: Possible link between visceral fat accumulation and vascular disease","volume":"46","author":"Alessi MC","year":"1997","journal-title":"Diabetes","ISSN":"https:\/\/id.crossref.org\/issn\/0012-1797","issn-type":"print"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.2337\/diab.43.11.1271","article-title":"Tumor necrosis factor-a: A key component of the obesity-diabetes link","volume":"43","author":"Hotamisligil GS","year":"1994","journal-title":"Diabetes","ISSN":"https:\/\/id.crossref.org\/issn\/0012-1797","issn-type":"print"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1073\/pnas.91.11.4854","article-title":"TNF-a inhibitors signaling from the insulin receptor","volume":"91","author":"Hotamisligil","year":"1994","journal-title":"Proc Natl Acad Sci USA","ISSN":"https:\/\/id.crossref.org\/issn\/0027-8424","issn-type":"print"},{"issue":"1","key":"ref72","first-page":"A297","article-title":"Interleukin-6 is associated UIT insulin resistance independently of obesity","volume":"49","author":"Hanson K","year":"2000","journal-title":"Diabetes","ISSN":"https:\/\/id.crossref.org\/issn\/0012-1797","issn-type":"print"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"651","DOI":"10.7326\/0003-4819-130-8-199904200-00014","article-title":"The role of leptin in human obesity and disease: A review of the current evidence","volume":"130","author":"Mantzoros CS","year":"1999","journal-title":"Ann Intern Med","ISSN":"https:\/\/id.crossref.org\/issn\/0003-4819","issn-type":"print"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jcem.86.5.7463","article-title":"Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia","volume":"86","author":"Weyer C","year":"2001","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/90984","article-title":"The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity","volume":"7","author":"Yamauchi T","year":"2001","journal-title":"Nat Med","ISSN":"https:\/\/id.crossref.org\/issn\/1078-8956","issn-type":"print"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1210\/jcem.87.5.8624","article-title":"Serum adiponectin and leptin levels in patients with lipodystrophies","volume":"87","author":"Haque WA","year":"2002","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"issue":"2","key":"ref77","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1210\/jc.2002-020795","article-title":"Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribuition in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy","volume":"88","author":"Addy CL","year":"2003","journal-title":"J Clin Endocrinol Metab","ISSN":"https:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1086\/367859","article-title":"Human immunodeficiency virus type 1-related lipoatrophy and lipohypertrophy are associated with serum concentrations of leptin","volume":"36","author":"Nagy GS","year":"2003","journal-title":"Clin Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1058-4838","issn-type":"print"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/nm0995-950","article-title":"Over expression of the obese (ob) gene in adipose tissue of human obese subjects","volume":"1","author":"Lonnqvist F","year":"1995","journal-title":"Nat Med","ISSN":"https:\/\/id.crossref.org\/issn\/1078-8956","issn-type":"print"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199602013340503","article-title":"Serum immunoreactive-leptin concentrations in normal weight and obese human","volume":"334","author":"Considine RV","year":"1996","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMoa012437","article-title":"Leptin-replacement therapy for lipodystrophy","volume":"346","author":"Oral EA","year":"2002","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00042560-200201010-00004","article-title":"Leptin and adipose tissue maldistribuition in HIV-infected male patients with predominant fat loss treated with antiretroviral therapy","volume":"29","author":"Estrada V","year":"2002","journal-title":"J Acquir Immune Defic Syndr","ISSN":"https:\/\/id.crossref.org\/issn\/0894-9255","issn-type":"print"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1097\/00002030-199911120-00007","article-title":"Lipodystrophy defined by a clinical score in HIV-infected men on highly active antiretroviral therapy: Correlation between dyslipidemia and steroid hormone alterations","volume":"13","author":"Christeff N","year":"1999","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00002030-200401230-00002","article-title":"Antiretroviral nucleoside and nucleotide analogues and mitochondria","volume":"18","author":"Cossariza A","year":"2004","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1097\/00002030-199911120-00008","article-title":"Subcutaneous adipocyte apoptosis in HIV-1 protease inhibitor-associated lipodystrophy","volume":"13","author":"Domingo P","year":"1999","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0140-6736(02)08094-7","article-title":"Association between altered expression of adipogenese factor SREBP1c in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance","volume":"359","author":"Bastard JP","year":"2002","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1101\/gad.12.20.3182","article-title":"Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP1c in adipose tissue: Model for congenital generalized lipodystrophy","volume":"12","author":"Shimomura I","year":"1998","journal-title":"Genes Dev","ISSN":"https:\/\/id.crossref.org\/issn\/0890-9369","issn-type":"print"},{"key":"ref88","article-title":"HIV antiretroviral treatment alters adipokine expression and insulin sensitivity of adipose tissue in vitro and in vivo","author":"Lagathu C","year":"2005","journal-title":"Biochimie","ISSN":"https:\/\/id.crossref.org\/issn\/0300-9084","issn-type":"print"}],"container-title":["Arquivos Brasileiros de Endocrinologia &amp; Metabologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abem\/v49n6\/27386.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T07:06:54Z","timestamp":1495696014000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-27302005000600004&lng=pt&tlng=pt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":88,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0004-27302005000600004"],"URL":"https:\/\/doi.org\/10.1590\/s0004-27302005000600004","relation":{},"ISSN":["0004-2730"],"issn-type":[{"value":"0004-2730","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}